AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) has received a short term rating of sell from experts at Zacks with a rank of 4. The stock has been rated an average of 2.75 by 12 Brokerage Firm. 1 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 10 Brokerage Firms have advised hold.
Other Equity analysts have also commented on the company shares. In the latest statement by the brokerage house, Bank of America reinstates its outlook on AmerisourceBergen Corporation (Holding Co) (NYSE:ABC). The current rating of the shares is Neutral, according to the research report released by the firm. The rating by the firm was issued on June 7, 2016.
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) shares are expected to touch $85.18 in the short term. This short term price target has been shared by 11 analysts. However, the standard deviation of short term price estimate has been valued at 7.39. The target price could hit $105 on the higher end and $77 on the lower end.
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) rose 0.26% or 0.2 points on Tuesday and made its way into the gainers of the day. After trading began at $76.49 the stock was seen hitting $76.7805 as a peak level and $76.05 as the lowest level. The stock ended up at $76.57. The daily volume was measured at 1,277,332 shares. The 52-week high of the share price is $115.41 and the 52-week low is $73.31. The company has a market cap of $16,528 million.
Shares of AmerisourceBergen Corporation rose by 1.4% in the last five trading days and 2.34% for the last 4 weeks. AmerisourceBergen Corporation has dropped 11.75% during the last 3-month period . Year-to-Date the stock performance stands at -25.54%.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally, the Company offers healthcare providers and pharmaceutical manufacturers with services, including reimbursement and pharmaceutical consulting services, logistics services, inventory management, pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.